Boston CEO Conference to Feature Prominent CEOs and Industry Leaders on May 31st and June 1st

Share Article

Join Governor Charlie Baker, Robert Coughlin (MassBio), Michelle Dipp (OvaScience), Deborah Dunsire (FORUM Pharmaceuticals), Kurt Graves (Intarcia Therapeutics), JC Gutierrez-Ramos (Synlogic Therapeutics), Jonathan Kraft (The Kraft Group), David Meeker (Genzyme), Lonnie Moulder (TESARO), Moncef Slaoui (GlaxoSmithKline) and others at the Four Seasons Boston for a two-day high-level, high-energy networking event.

Leading CEOs from biotech, pharmaceutical, and healthcare investing communities will gather at Boston CEO 2016 on May 31st and June 1st at The Four Seasons Hotel Boston.

The Boston CEO Conference is an off-the-record networking forum for leading executives in the life sciences, offering exclusive access to key decision makers who influence deal making and investment. Attendees gain insight from presentations and panels featuring CEOs from several of the world’s leading biopharmaceutical companies. Healthcare and finance investors also attend this world-class meeting.

Governor Charlie Baker and Congressman Joseph P. Kennedy III will each give a keynote speech moderated by Christoph Westphal (Longwood Fund). Panel topics include understanding and managing growth, ensuring diversity, oncology trends and predictions, how sustainable is the rare disease business model?, innovation via M&A and partnerships, advances in personalized medicine and many more.

Henri Termeer, former CEO of Genzyme says, "Every year I look forward to Boston CEO, the elite meeting for leaders in biotech. This top notch meeting features unrivaled networking and candid discussions on the most pressing topics facing the industry.”

“I always look forward to the Boston CEO Conference because it brings so many of the industry’s best minds together to exchange views on key challenges facing our industry,” adds David Barrow, Managing Director and Head of the Biopharma, Life Sciences and MedTech practice for the Americas at L.E.K. Consulting. “Clients often tell me they come away reinvigorated with fresh ideas that can have a practical impact on their business.”

The 2016 Boston CEO Lifetime Achievement Award will be presented by last year’s winner, John Maraganore (Alnylam) on Tuesday, June 1st at 4:50 pm.

Boston CEO is sponsored by Alexandria, L.E.K. Consulting, H.C. Wainwright & Co., Fenwick & West LLP, Silicon Valley Bank, Russell Reynolds Associates, RSM International, ICON plc, Perspective Group, and BioPharma Executive Council.

For more information or to register for the conference, visit:


The Boston Biotech Conferences (BBC)’s mission is to build a vibrant community of biopharma leaders, which will help to drive innovation in biotech by convening leaders across industry and academia.

The conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These off-the-record forums bring together the past, present and future leaders in the healthcare community to network, exchange ideas and share insights into the industry's challenges and opportunities.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cristina Ojeda
Follow >
Boston Biotech Conferences
since: 05/2012
Like >
Visit website